2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report

• Published in: Kidney international reports Vol. 5; no. 8; pp. 1129 - 1138
• Main Authors: Li, Philip Kam-Tao, Bavanandan, Sunita, Mohamed, Rosmawati, Szeto, Cheuk-Chun, Wong, Vincent Wai-Sun, Chow, Kai-Ming, Dan, Yock-Young, Huang, Chiu-Ching, Lai, Ching-Lung, Tanwandee, Tawesak, Teo, Boon Wee, Wong, Grace Lai-Hung, Yeoh, Eng-Kiong, Iseki, Kunitoshi, Leung, Chi-Bon, Park, Hyeong Cheon, Kanjanabuch, Talerngsak, Lu, Wanhong, Fung, James, Jia, Jidong, Kanda, Eiichiro, Law, Man-Ching, Liu, Hong, Loo, Ching-Kong, Mak, Siu-Ka, Lui, Sing-Leung, Tang, Hon-Lok, Wang, Angela Yee-Moon, Yu, Ming-Lung, Cheung, Michael, Jadoul, Michel
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.08.2020; Elsevier
• Subjects: chronic kidney disease; dialysis; direct-acting antiviral; infection control; kidney transplantation; Meeting Report; dialysis; direct-acting antiviral; chronic kidney disease; infection control; kidney transplantation
• ISSN: 2468-0249; 2468-0249
• DOI: 10.1016/j.ekir.2020.05.001

In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.